These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9464825)

  • 1. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
    Fisch P; Meuer E; Pende D; Rothenfusser S; Viale O; Kock S; Ferrone S; Fradelizi D; Klein G; Moretta L; Rammensee HG; Boon T; Coulie P; van der Bruggen P
    Eur J Immunol; 1997 Dec; 27(12):3368-79. PubMed ID: 9464825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1).
    Eberl M; Engel R; Aberle S; Fisch P; Jomaa H; Pircher H
    J Leukoc Biol; 2005 Jan; 77(1):67-70. PubMed ID: 15498816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
    Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
    Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
    Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
    Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
    J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells.
    Fisch P; Oettel K; Fudim N; Surfus JE; Malkovsky M; Sondel PM
    J Immunol; 1992 Apr; 148(8):2315-23. PubMed ID: 1532810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria.
    D'Ombrain MC; Hansen DS; Simpson KM; Schofield L
    Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of a stimulatory activity for Vgamma9/Vdelta2 T cells by a Burkitt's lymphoma cell line without loss of HLA class I expression.
    L'Faqihi FE; Guiraud M; Dastugue N; Brousset P; Le Bouteiller P; Halary F; Bonneville M; Fournié JJ; Champagne E
    Hum Immunol; 1999 Oct; 60(10):928-38. PubMed ID: 10566592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
    Kress E; Hedges JF; Jutila MA
    Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cells.
    Sturm E; Braakman E; Fisch P; Vreugdenhil RJ; Sondel P; Bolhuis RL
    J Immunol; 1990 Nov; 145(10):3202-8. PubMed ID: 2146317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.
    Poggi A; Contini P; Catellani S; Setti M; Murdaca G; Zocchi MR
    Eur J Immunol; 2005 Sep; 35(9):2670-8. PubMed ID: 16114098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
    Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
    Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for CD4+ T cells in the gammadelta T cell proliferative response to Daudi Burkitt's lymphoma.
    Burns J; Lobo S; Bartholomew B
    Cell Immunol; 1996 Nov; 174(1):19-24. PubMed ID: 8929450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of V gamma 9V delta 2 T cells by NKG2D.
    Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
    J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
    Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.